JP2001517922A5 - - Google Patents

Download PDF

Info

Publication number
JP2001517922A5
JP2001517922A5 JP1997505925A JP50592597A JP2001517922A5 JP 2001517922 A5 JP2001517922 A5 JP 2001517922A5 JP 1997505925 A JP1997505925 A JP 1997505925A JP 50592597 A JP50592597 A JP 50592597A JP 2001517922 A5 JP2001517922 A5 JP 2001517922A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997505925A
Other languages
English (en)
Japanese (ja)
Other versions
JP4073955B2 (ja
JP2001517922A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1996/011386 external-priority patent/WO1997003192A2/en
Publication of JP2001517922A publication Critical patent/JP2001517922A/ja
Publication of JP2001517922A5 publication Critical patent/JP2001517922A5/ja
Application granted granted Critical
Publication of JP4073955B2 publication Critical patent/JP4073955B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP50592597A 1995-07-07 1996-07-05 アルツハイマー病に関連する第1染色体の遺伝子および遺伝子産物 Expired - Fee Related JP4073955B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US95695P 1995-07-07 1995-07-07
US167595P 1995-07-28 1995-07-28
US217495P 1995-08-11 1995-08-11
US232895P 1995-08-14 1995-08-14
US60/000,956 1995-08-14
US60/002,328 1995-08-14
US60/001,675 1995-08-14
US60/002,174 1995-08-14
PCT/US1996/011386 WO1997003192A2 (en) 1995-07-07 1996-07-05 Chromosome 1 gene and gene products related to alzheimer's disease

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2007206901A Division JP2008035863A (ja) 1995-07-07 2007-08-08 アルツハイマー病に関連する変異ad4タンパク質の利用
JP2007206900A Division JP2008035862A (ja) 1995-07-07 2007-08-08 アルツハイマー病に関連する変異ad4タンパク質

Publications (3)

Publication Number Publication Date
JP2001517922A JP2001517922A (ja) 2001-10-09
JP2001517922A5 true JP2001517922A5 (https=) 2004-08-19
JP4073955B2 JP4073955B2 (ja) 2008-04-09

Family

ID=27485043

Family Applications (3)

Application Number Title Priority Date Filing Date
JP50592597A Expired - Fee Related JP4073955B2 (ja) 1995-07-07 1996-07-05 アルツハイマー病に関連する第1染色体の遺伝子および遺伝子産物
JP2007206901A Withdrawn JP2008035863A (ja) 1995-07-07 2007-08-08 アルツハイマー病に関連する変異ad4タンパク質の利用
JP2007206900A Withdrawn JP2008035862A (ja) 1995-07-07 2007-08-08 アルツハイマー病に関連する変異ad4タンパク質

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007206901A Withdrawn JP2008035863A (ja) 1995-07-07 2007-08-08 アルツハイマー病に関連する変異ad4タンパク質の利用
JP2007206900A Withdrawn JP2008035862A (ja) 1995-07-07 2007-08-08 アルツハイマー病に関連する変異ad4タンパク質

Country Status (7)

Country Link
US (2) US6468791B1 (https=)
EP (2) EP1637600A1 (https=)
JP (3) JP4073955B2 (https=)
AT (1) ATE305039T1 (https=)
CA (1) CA2226255A1 (https=)
DE (1) DE69635207T2 (https=)
WO (1) WO1997003192A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531586B1 (en) 1995-04-28 2003-03-11 The Hospital For Sick Children Genetic sequences related to Alzheimer's Disease
JP5379119B2 (ja) * 1995-04-28 2013-12-25 エイチエスシー リサーチ アンド ディベロップメント リミテッド アルツハイマー病に関連する遺伝子配列およびタンパク質、ならびにその使用
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
US6210919B1 (en) 1995-04-28 2001-04-03 Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
EP0846172A2 (en) * 1995-08-16 1998-06-10 The President And Fellows Of Harvard College Assay for identifying genes causing chromosome non-disjunction
JP2000506375A (ja) * 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
ES2128265B1 (es) * 1997-06-04 2000-03-01 Euroespes S A Kit genetico para la caracterizacion molecular de la enfermedad de alzheimer.
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US6761888B1 (en) 2000-05-26 2004-07-13 Neuralab Limited Passive immunization treatment of Alzheimer's disease
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US7588766B1 (en) 2000-05-26 2009-09-15 Elan Pharma International Limited Treatment of amyloidogenic disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
AU1957299A (en) 1998-01-09 1999-07-26 Governing Council Of The University Of Toronto, The Presenilin protein interactions
PE20020574A1 (es) 2000-12-06 2002-07-02 Wyeth Corp Anticuerpos humanizados que reconocen el peptido amiloideo beta
US7700751B2 (en) 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
JP2003018991A (ja) * 2001-06-27 2003-01-21 Japan Science & Technology Corp プレセニリン−2遺伝子エキソン5欠損型スプライシング異常の生成に関与する核酸
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
TWI306458B (en) 2003-05-30 2009-02-21 Elan Pharma Int Ltd Humanized antibodies that recognize beta amyloid peptide
EP1838348B1 (en) 2004-12-15 2013-06-26 Janssen Alzheimer Immunotherapy Humanized amyloid beta antibodies for use in improving cognition
US7625560B2 (en) 2004-12-15 2009-12-01 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
JP5124569B2 (ja) * 2006-06-12 2013-01-23 カー−バー インヴェストメンツ インコーポレイテッド ノズル検査装置および方法
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
DK2182983T3 (da) 2007-07-27 2014-07-14 Janssen Alzheimer Immunotherap Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
BR112014013942B1 (pt) * 2011-12-20 2021-03-02 Unilever Ip Holdings B.V composição detergente líquida isotrópica
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210919B1 (en) * 1995-04-28 2001-04-03 Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease

Similar Documents

Publication Publication Date Title
JP2000500228A5 (https=)
JP2000500445A5 (https=)
JP2000500033A5 (https=)
JP2000500440A5 (https=)
JP2000500327A5 (https=)
JP2000500145A5 (https=)
JP2000500155A5 (https=)
JP2000500406A5 (https=)
JP2000500361A5 (https=)
JP2000500115A5 (https=)
JP2000500322A5 (https=)
JP2000500258A5 (https=)
JP2000500342A5 (https=)
JP2000500192A5 (https=)
JP2000500112A5 (https=)
JP2000500226A5 (https=)
JP2000500051A5 (https=)
JP2000500397A5 (https=)
JP2000500407A5 (https=)
JP2000500166A5 (https=)
JP2000500019A5 (https=)
JP2000500125A5 (https=)
JP2000500346A5 (https=)
JP2000500044A5 (https=)
JP2001517922A5 (https=)